What is Lifemd Inc share price today?

Lifemd Inc (LFMD) share price today is {{live_price}}.

Can Indians buy Lifemd Inc shares?

Yes, Indians can invest in the Lifemd Inc (LFMD) from India. With INDmoney, you can buy Lifemd Inc at 0 brokerage. The step-by-step process is as follows: Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes) Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates. Once funds are transferred successfully, you can buy Lifemd Inc at zero transaction cost.

How can I buy Lifemd Inc shares from India?

It is very easy to buy Lifemd Inc from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Lifemd Inc be purchased?

Yes, you can buy fractional shares of Lifemd Inc with INDmoney app.

What are the documents required to start investing in Lifemd Inc stocks?

To start investing in Lifemd Inc, You will need the following documents: Proof of Identification (PAN, Aadhaar etc) Proof of address (Aadhaar, Voter ID etc) These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Lifemd Inc

Today’s highest price of Lifemd Inc (LFMD) is {{1_rba_end}}. Today’s lowest price of Lifemd Inc (LFMD) is {{1_rba_st}}.

What is today's market capitalisation of Lifemd Inc

Today's market capitalisation of Lifemd Inc LFMD is 197.3M

What is the 52 Week High and Low Range of Lifemd Inc

52 Week High {{rba_end}} 52 Week Low {{rba_st}}

How much percentage Lifemd Inc is down from its 52 Week High?

Lifemd Inc (LFMD) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

How much percentage Lifemd Inc is up from its 52 Week low?

Lifemd Inc (LFMD) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

What are the historical returns of Lifemd Inc?

1 Month Returns {{1mr}}% 3 Months Returns {{3mr}}% 1 Year Returns {{1yr}}% 5 Years Returns {{5yr}}%

Who is the Chief Executive Officer (CEO) of Lifemd Inc

Mr. Justin Schreiber is the current Chief Executive Officer (CEO) of Lifemd Inc.

Home>
US Stocks>
Lifemd Inc

Lifemd Inc (LFMD)

$4.53

-0.15

(-3.21%)▲

Live

Performance

$4.51
$4.79
$4.53
0.44%
Downside
Day's Volatility :5.85%
Upside
5.43%
$4.10
$12.88
$4.53
9.49%
Downside
52 Weeks Volatility :68.17%
Upside
64.83%

Returns

Period	Lifemd Inc	Sector (Consumer Staples)	Index (Russel 2000)
3 Months	-32.66%	5.3%	0.0%
6 Months	-53.2%	10.5%	0.0%
1 Year	-29.84%	22.3%	0.0%
3 Years	-11.03%	16.3%	-23.0%

Highlights

Market Capitalization	197.3M
Book Value	-$0.10
Earnings Per Share (EPS)	-0.7
Wall Street Target Price	12.57

Profit Margin	-13.18%
Operating Margin TTM	-12.45%

Return On Assets TTM	-24.2%
Return On Equity TTM	-782.48%

Revenue TTM	178.3M
Revenue Per Share TTM	4.7
Quarterly Revenue Growth YOY	40.9%
Gross Profit TTM	100.4M
EBITDA	-18.0M
Diluted Eps TTM	-0.7
Quarterly Earnings Growth YOY	0.0

EPS Estimate Current Year	-0.52
EPS Estimate Next Year	-0.04
EPS Estimate Current Quarter	-0.12
EPS Estimate Next Quarter	-0.03

Analyst Recommendation

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Lifemd Inc(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast

What analysts predicted

Upside of 177.48%

Current $4.53

Target $12.57

Company Financials

	FY18	Y/Y Change
Revenue	8.3M	↑ 64.68%
Net Income	-1.2M	↑ 2.89%
Net Profit Margin	-14.91%	↑ 8.95%

	FY19	Y/Y Change
Revenue	12.5M	↑ 49.79%
Net Income	-3.5M	↑ 184.35%
Net Profit Margin	-28.3%	↓ 13.39%

	FY20	Y/Y Change
Revenue	37.3M	↑ 199.1%
Net Income	-60.5M	↑ 1615.42%
Net Profit Margin	-162.29%	↓ 133.99%

	FY21	Y/Y Change
Revenue	92.9M	↑ 149.04%
Net Income	-61.3M	↑ 1.32%
Net Profit Margin	-66.03%	↑ 96.26%

	FY22	Y/Y Change
Revenue	119.0M	↑ 28.16%
Net Income	-45.0M	↓ 26.59%
Net Profit Margin	-37.82%	↑ 28.21%

	FY23	Y/Y Change
Revenue	152.5M	↑ 28.15%
Net Income	-20.6M	↓ 54.25%
Net Profit Margin	-13.5%	↑ 24.32%

	Q1 FY23	Q/Q Change
Revenue	33.1M	↑ 17.8%
Net Income	-10.1M	↓ 12.89%
Net Profit Margin	-30.44%	↑ 10.72%

	Q2 FY23	Q/Q Change
Revenue	35.9M	↑ 8.51%
Net Income	-6.7M	↓ 33.22%
Net Profit Margin	-18.73%	↑ 11.71%

	Q3 FY23	Q/Q Change
Revenue	38.6M	↑ 7.42%
Net Income	-6.1M	↓ 9.07%
Net Profit Margin	-15.86%	↑ 2.87%

	Q4 FY23	Q/Q Change
Revenue	44.9M	↑ 16.18%
Net Income	-3.7M	↓ 39.04%
Net Profit Margin	-8.32%	↑ 7.54%

	Q1 FY24	Q/Q Change
Revenue	44.1M	↓ 1.6%
Net Income	-6.8M	↑ 81.36%
Net Profit Margin	-15.33%	↓ 7.01%

	Q2 FY24	Q/Q Change
Revenue	50.7M	↑ 14.76%
Net Income	-6.9M	↑ 1.59%
Net Profit Margin	-13.57%	↑ 1.76%

	FY18	Y/Y Change
Total Assets	2.6M	↑ 107.0%
Total Liabilities	1.8M	↑ 180.26%

	FY19	Y/Y Change
Total Assets	3.4M	↑ 31.73%
Total Liabilities	4.6M	↑ 154.7%

	FY20	Y/Y Change
Total Assets	13.1M	↑ 278.79%
Total Liabilities	13.9M	↑ 203.26%

	FY21	Y/Y Change
Total Assets	49.9M	↑ 282.45%
Total Liabilities	24.1M	↑ 73.72%

	FY22	Y/Y Change
Total Assets	25.7M	↓ 48.59%
Total Liabilities	33.0M	↑ 36.79%

	FY23	Y/Y Change
Total Assets	58.5M	↑ 127.85%
Total Liabilities	52.9M	↑ 60.49%

	Q1 FY23	Q/Q Change
Total Assets	33.9M	↑ 31.96%
Total Liabilities	41.2M	↑ 25.05%

	Q2 FY23	Q/Q Change
Total Assets	35.4M	↑ 4.65%
Total Liabilities	45.7M	↑ 10.72%

	Q3 FY23	Q/Q Change
Total Assets	40.7M	↑ 14.8%
Total Liabilities	51.8M	↑ 13.41%

	Q4 FY23	Q/Q Change
Total Assets	58.5M	↑ 43.72%
Total Liabilities	52.9M	↑ 2.2%

	Q1 FY24	Q/Q Change
Total Assets	61.5M	↑ 5.09%
Total Liabilities	60.2M	↑ 13.69%

	Q2 FY24	Q/Q Change
Total Assets	63.8M	↑ 3.85%
Total Liabilities	65.9M	↑ 9.51%

	FY18	Y/Y Change
Operating Cash Flow	-905.5K	↑ 10.81%
Investing Cash Flow	141.4K	↑ 0.0%
Financing Cash Flow	802.8K	↑ 3.45%

	FY19	Y/Y Change
Operating Cash Flow	251.4K	↓ 127.76%
Investing Cash Flow	-100.0K	↓ 170.7%
Financing Cash Flow	775.1K	↓ 3.45%

	FY20	Y/Y Change
Operating Cash Flow	-12.1M	↓ 4925.47%
Investing Cash Flow	-798.1K	↑ 698.14%
Financing Cash Flow	21.0M	↑ 2609.53%

	FY21	Y/Y Change
Operating Cash Flow	-33.1M	↑ 172.72%
Investing Cash Flow	-3.4M	↑ 326.28%
Financing Cash Flow	68.6M	↑ 226.81%

	FY22	Y/Y Change
Operating Cash Flow	-22.9M	↓ 30.68%
Investing Cash Flow	-13.9M	↑ 308.72%
Financing Cash Flow	-528.2K	↓ 100.77%

	Q1 FY23	Q/Q Change
Operating Cash Flow	-2.6M	↑ 32.75%
Investing Cash Flow	-1.8M	↑ 2.29%
Financing Cash Flow	12.0M	↑ 543.94%

	Q2 FY23	Q/Q Change
Operating Cash Flow	4.6M	↓ 277.68%
Investing Cash Flow	-2.3M	↑ 27.03%
Financing Cash Flow	-2.0M	↓ 116.35%

Technicals Summary

Sell

Neutral

Buy

Lifemd Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Lifemd Inc	-8.59%	-53.2%	-29.84%	-11.03%	568.57%
Solventum Corp	5.08%	18.7%	6.63%	6.63%	6.63%
Tempus Ai	-10.87%	22.58%	22.58%	22.58%	22.58%
Veeva Systems Inc.	4.87%	11.18%	13.42%	-31.95%	52.57%
Ge Healthcare Technologies Inc.	0.51%	8.34%	42.74%	51.0%	51.0%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Lifemd Inc	NA	NA	NA	-0.52	-7.82	-0.24	NA	-0.1
Solventum Corp	NA	NA	NA	6.26	0.17	0.08	NA	NA
Tempus Ai	NA	NA	NA	-2.41	0.0	0.0	NA	0.64
Veeva Systems Inc.	57.72	57.72	1.25	4.76	0.13	0.06	NA	32.04
Ge Healthcare Technologies Inc.	26.25	26.25	2.37	4.25	0.21	0.06	0.0	17.08

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Lifemd Inc	Buy	$197.3M	568.57%	NA	-13.18%
Solventum Corp	Hold	$10.8B	6.63%	NA	15.73%
Tempus Ai	NA	$7.9B	22.58%	NA	-121.04%
Veeva Systems Inc.	Buy	$35.1B	52.57%	57.72	23.91%
Ge Healthcare Technologies Inc.	Buy	$41.7B	51.0%	26.25	8.1%

Insights on Lifemd Inc

Increasing Revenue
Revenue is up for the last 2 quarters, 44.14M → 50.66M (in $), with an average increase of 12.9% per quarter
Decreasing Net Profit
Netprofit is down for the last 3 quarters, -3.73M → -6.87M (in $), with an average decrease of 41.5% per quarter
Vs GEHC
In the last 1 year, Ge Healthcare Technologies Inc. has given 42.6% return, outperforming this stock by 69.6%